• Far broader and more inclusive of Babesia species than standard serologies.
• Detects antibodies to Babesia from around the world
• Provides a simple, cost-effective, yes/no result with no complicated interpretation necessary
$195.00
The Babesia Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to Babesia antigens in human serum. A positive test suggests exposure to Babesia , and should be used in conjunction with patient clinical symptoms and history. The BCA Assay is a simple and cost-effective test, which gives either a positive or negative result.
Principle
Detects IgM and IgG antibodies to Babesia , and a positive test suggests exposure to Babesia , and should be used in conjunction with patient clinical symptoms and history. For specific protein or band information, an ImmunoBlot IgM or IgG test should be ordered to provide more information and possible speciation of the Babesia. The sensitivity of the Babesia BCA Assay is greater than 90%, and the specificity is greater than 94%.
Tube / Specimen Requirements
1 SST/ minimum volume 0.5mL serum
CPT Code(s)
86318
Any Stage of Disease
Test MethodologyImmunoBlot
Available in New YorkNo
• Far broader and more inclusive of Babesia species than standard serologies.
• Detects antibodies to Babesia from around the world
• Provides a simple, cost-effective, yes/no result with no complicated interpretation necessary
Positive: Babesia antigens detected.
Negative: Babesia antigens not detected
A positive result suggests exposure to Babesia. For diagnostic purposes, test results should be used in conjunction with clinical symptoms and other evidence available to the diagnosing physician. If the test result is indeterminate, testing with another method or retesting in 6-8 weeks is recommended.
The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.
1.800.832.3200
For the most up to date and accurate information and articles about ticks and tick-borne diseases, please visit Tick Talk Resource.
Enter your email address to receive periodic marketing communications from IGeneX.